HR 7567
116th Congress
House
Health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug therapy
European Union
Government information and archives
Government studies and investigations
Health care coverage and access
Health information and medical records
Licensing and registrations
Prescription drugs
Helping Experts Accelerate Rare Treatments Act of 2020
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 9, 2020
Referred to the House Committee on Energy and Commerce.
Jul 9, 2020
Introduced in House
Plain-English summary
Helping Experts Accelerate Rare Treatments Act of 2020
This bill addresses rare diseases, including by requiring the Food and Drug Administration to ensure the inclusion of rare disease experts and staff members in various parts of the drug review process.
The bill also requires certain reports to address issues related to rare diseases and drugs for treating such diseases (sometimes referred to as orphan drugs if the rarity of the disease makes it difficult for the drug to be profitable).
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1